Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 409–432 of 3,255 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Device Clear all

Conditions: Parkinson Disease
Interventions: SpeechVive device, Telemedicine interaction, In person interaction; Device · Behavioral
Lead sponsor: SpeechVive, Inc; Industry
Eligibility: 30 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Lafayette, Indiana • West Lafayette, Indiana

Conditions: Bile Duct Carcinoma, Gallbladder Carcinoma, Pancreatic Ductal Adenocarcinoma
Interventions: Endoscopic Retrograde Cholangiopancreatography; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Heart Failure, Cardiomyopathies
Interventions: EXCOR Pediatric; Device
Lead sponsor: Berlin Heart, Inc; Industry
Eligibility: 1 Day to 16 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 15
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Palo Alto, California + 12 more

Conditions: Liver Cancer, Portal Vein Thrombosis
Interventions: TheraSphere; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Colorectal Adenoma, Colorectal Polyp, Colorectal Adenocarcinoma, Colorectal SSA
Interventions: Ultivision Artificial Intelligence Software, No Artificial Intelligence Software enhancement; Device
Lead sponsor: Docbot, Inc.; Industry
Eligibility: 45 Years to 75 Years
Enrollment: 978 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 9
States / cities: Birmingham, Alabama • San Diego, California • Kansas City, Kansas + 6 more

Conditions: Cesarean Delivery Procedures
Interventions: Uterine drain for use in cesarean section; Device
Lead sponsor: Lucie Medical Inc; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Surgery
Interventions: O3 regional oximeter sensor; Device
Lead sponsor: Masimo Corporation; Industry
Eligibility: 1 Day to 18 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Intravenous Access
Interventions: IV SafeLock; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Sanfilippo Syndrome Type A
Interventions: GC1130A; Drug
Lead sponsor: GC Biopharma Corp; Industry
Eligibility: 12 Months to 18 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Oakland, California • Minneapolis, Minnesota

Conditions: Barrett Esophagus, Dysplasia, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Reflux Disease, Metaplasia
Interventions: Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Swallowable Sponge Cell Sampling Device; Other · Device
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Atopic Dermatitis
Interventions: pimecrolimus, topical medical device; Drug · Device
Lead sponsor: Emer, Jason, M.D.; Individual
Eligibility: 2 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Veins
Interventions: Not listed
Lead sponsor: Christie Medical Holdings, Inc.; Industry
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Percutaneous Large Hole Vascular Closure
Interventions: PPCI, Cardiogenic shock; Device
Lead sponsor: Vivasure Medical Limited; Industry
Eligibility: 19 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 4
States / cities: Ridgewood, New Jersey • Buffalo, New York • Stony Brook, New York + 1 more

Conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, T-Cell, Juvenile Myelomonocytic Leukemia Lymphoblastic, T-cell Lymphoblastic Lymphoma, Myelodysplastic Syndrome
Interventions: Haploidentical donor derived natural killer cell infusion, Chemotherapy, CliniMACS; Procedure · Drug · Device
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 18 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Electrophysiology Study, Ablation
Interventions: Peritorq; Device
Lead sponsor: University of Minnesota; Other
Eligibility: Up to 21 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Minneapolis, Minnesota

Conditions: Malaria (Plasmodium Falciparum)
Interventions: PfSPZ Challenge (NF54), Wearable Biosensor Devices, Placebo; Biological · Device · Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 50 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Low Back Pain
Interventions: Continuous Passive Motion; Device
Lead sponsor: Radiancy; Industry
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Cornea
Interventions: Observational; Other
Lead sponsor: Tomey Corporation; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Orthostatic Hypotension
Interventions: Inspiratory Threshold Device (Res-Q-Gard ITD), Sham Inspiratory Threshold Device; Device
Lead sponsor: Alfredo Gamboa; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Urinary Tract Infections, Proteinuria, Ketone Urine, Hematuria, Glucose Intolerance
Interventions: Scanadu Urine Device; Device
Lead sponsor: Scanadu, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 2
States / cities: Mountain View, California • San Leandro, California

Conditions: Cardiovascular Disease
Interventions: discharge vs. overnight stay; Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 75 Years
Enrollment: 303 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: New York, New York • Dallas, Texas

Conditions: All Conditions, All
Interventions: Not listed
Lead sponsor: Head Diagnostics; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Atlanta, Georgia • Cambridge, Massachusetts

Conditions: Heart Failure
Interventions: Mobile phone app (VAD Care App), Usual LVAD Care; Device · Other
Lead sponsor: University of Michigan; Other
Eligibility: 21 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 3
States / cities: St Louis, Missouri • Lincoln, Nebraska • New York, New York

Conditions: Healthy Volunteers
Interventions: Vedolizumab SC; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Tempe, Arizona

Search by objective public record fields.

Development of Software to Provide the SpeechVive Device Via the Internet

A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP

Assess Safety and Probable Benefit of the EXCOR® Pediatric Ventricular Assist Device

TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis

To Compare Artificial Intelligence Software Aided Adenoma Detection in Screening Colonoscopies Versus Standard Colonoscopy Without Artificial Intelligence Software Assistance in Participants Between 45 and 75 Years of Age

KIRA Uterine Drain Device Evaluation- First-In- Human Study

Calibration and Validation of Masimo's O3 Regional Oximetry Device in Neonates, Infants and Children

IV SafeLock Device Functionality in Emergency Department

Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)

Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease

Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.

Percentage Venous Options in Pediatrics & Adults

PerQseal® Impella Early Feasibility Study

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors

Torque Device Evaluation

Malaria CVD 36000; Gates INV090205

The Efficacy of the Kyrobak for Chronic Low Back Pain (LBP-2)

To Investigate Agreement Between the EM-3000 and the Predicate Device Noncon Robo Pachy (F&A) (CellChek XL)

Breathing Device for Orthostatic Hypotension (OH)

Scanadu Urine Device Validation Study Protocol

Same Day Versus Next Day Discharge: Ambulatory Closure Device Percutaneous Intervention

Measurement of Ocular Microtremor With the iTremor Device in a Diverse US Cohort

Self-Management App for Patients With Left-Ventricular Assist Devices

A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants